Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBALT trial of memantine added to cholinesterase inhibitor therapy in Lewy body dementia
ISRCTN79794378Phase 3Active, not recruiting
- Sponsor
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
- Start
- Nov 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) comparing Memantine add-on with Placebo add-on (2 arms). Primary endpoint: Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change. Started Nov 2022; status: active, not recruiting.
02
Drugs
memantine
03
Conditions
dementia with Lewy bodies (DLB)Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on ISRCTN79794378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN79794378.